baha the information company

baha is a leading provider of real-time market data, financial news, technology and solutions for the financial industry. baha offers real-time data terminals for professionals, global financial market data covering over 12 million financial instruments on more than 150 exchanges, as well as 24/7 breaking news with global coverage and free web and mobile apps. From a total of around 200 real-time data providers worldwide, only Reuters 1851, Bloomberg 1981 and now baha in 2021 were named after the founder.

Teva Pharmaceutical Industries Lt.../ IL0006290147 /

2024-05-29 3:30:00 PM	Chg. -	Volume	Bid-	Ask-	High	Low
14.9200USD	-	300 Turnover: 4,476	-Bid Size: -	-Ask Size: -	14.9200	14.9200

GlobeNewswire 05-29 Alvotech to Participate in Jefferies Healthcare Conference in New York, June 5-6, 2024

GlobeNewswire 05-21 Alvotech Reports Financial Results for First Quarter of 2024 and Provides a Business Update

GlobeNewswire 05-21 Alvotech and Dr. Reddy’s enter into collaboration for commercialization of AVT03 (denosumab), a bios...

GlobeNewswire 05-21 Teva and Alvotech Announce SIMLANDI® (adalimumab-ryvk) Injection Now Available in the U.S.

GlobeNewswire 05-13 Alvotech Announces Webcast of First Quarter 2024 Financial Results on May 22, 2024, at 8:00 am EDT (...

GlobeNewswire 05-02 Alvotech Announces Participation at BofA Securities Healthcare Conference 2024

GlobeNewswire 04-30 U.S. Commercialization Agreement with Quallent to Drive Patient Savings with First High-Concentratio...

GlobeNewswire 04-24 Alvotech Announces Topline Results from a Confirmatory Clinical Study for AVT05, a Proposed Biosimil...

GlobeNewswire 04-19 Alvotech signs U.S. agreement to expand access for newly approved high-concentration interchangeable...

GlobeNewswire 04-16 Alvotech and Teva Announce U.S. FDA Approval of SELARSDI™ (ustekinumab-aekn), biosimilar to Stelara®...

GlobeNewswire 04-03 Alvotech Hosts Audio Call for Investors at 8:15 am EDT on April 3, 2024

GlobeNewswire 03-22 Alvotech Announces Increase in Number of Own Shares

GlobeNewswire 03-20 Alvotech Reports Financial Results for Full Year 2023 and Provides a Business Update

GlobeNewswire 03-06 iTeos Appoints Oncology Veteran Jill DeSimone to Its Board of Directors

GlobeNewswire 03-05 Alvotech Announces Webcast of Full Year 2023 Financial Results on March 21, 2024, at 8:00 am ET

GlobeNewswire 02-29 Alvotech Appoints Interim Chief Quality Officer

GlobeNewswire 02-26 Alvotech Accepts Offer for the Sale of Shares for a value of approximately USD 166 million at a Purc...

GlobeNewswire 02-24 Alvotech and Teva Announce U.S. Approval of SIMLANDI® (adalimumab-ryvk) injection, the first interc...

GlobeNewswire 02-21 AdhereTech Announces Appointment of Paul Sekhri to Board of Directors

GlobeNewswire 02-15 Alvotech Announces Expected Global Market Entry Dates for AVT04 Biosimilar to Stelara® (ustekinumab)

GlobeNewswire 02-08 Acrivon Therapeutics Appoints Seasoned Industry Executive Ivana Magovčević-Liebisch, Ph.D., J.D., to...

GlobeNewswire 01-31 Orange Grove Bio Sets Sights on Rapidly Emerging Middle East Biotech Ecosystem through New Academic ...

GlobeNewswire 01-29 Alvotech Announces Positive Top-Line Results from a Pharmacokinetic Study for AVT03, a Proposed Bios...

GlobeNewswire 01-19 Alvotech Provides Update on Status of Biologics License Applications for AVT02 and AVT04

GlobeNewswire 01-10 STADA and Alvotech secure approval for Uzpruvo, Europe’s first ustekinumab biosimilar to Stelara

Teva Pharmaceutical Industries Lt.../ IL0006290147 /

If you wish to receive reply to your feedback, please provide your email address.